The 65th ESPE annual meeting takes place from 29 April to 1 May 2027 in Gothenburg, with a free pre-meeting day on growth and sex steroids....
Cervical cancer is one of the few tumours medicine can stop before it appears, and cytology — the Pap test — is the tool that makes it possible. But screening only works if it reaches ever...
WPATH holds its 29th Scientific Symposium from 7 to 12 November 2026 in Mexico City, with a surgical pre-conference and three days of main programme....
Every year, thousands of transgender men go through surgery for a hysterectomy with removal of the ovaries and fallopian tubes as part of their medical transition. Before that operation they have spen...
Twenty fingers pressing on the arm of the clinic chair. An electrocardiogram. A blood test with fifteen parameters. And the same question as always: what is testosterone doing to my body, year after y...
How can we know whether a gender-affirming hormone dose is right? Until now, the answer has relied largely on clinical experience and on each person’s symptoms. A new study published in the jour...
The immune system is the body’s network of defenses. And, like many other functions, it also shifts when a transgender person starts gender-affirming hormone therapy. A team from Ghent Universit...
For many transgender women, the voice is one of the hardest fronts of transition. Although hormone therapy produces visible changes in the body, it does not by itself change the pitch of the voice, be...
Gender-affirming hormone therapy is the cornerstone of treatment for many transgender people, but its effects go far beyond the visible changes: they also reach internal organs such as the kidney. A n...
Transgender and nonbinary people assigned female at birth face an elevated cardiovascular risk. For years, suspicion has focused on the testosterone used in gender-affirming treatment. But there is an...
Gender-affirming hormone therapy does not simply change appearance or the endocrine balance: its effects reach as far as the way cells regulate DNA without altering its letters. One open question was ...
Gender-affirming hormone therapy is no longer a brief stage in the life of a transgender person. As the general population ages, more and more trans and gender-diverse (TGD) people reach 60, 70 and be...












